- Home
- FATE vs FORR Comparison
FATE vs FORR Comparison
Compare FATE & FORR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATE
- FORR
- Stock Information
- Founded
- FATE 2007
- FORR 1983
- Country
- FATE United States
- FORR United States
- Employees
- FATE N/A
- FORR N/A
- Industry
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- FORR Diversified Commercial Services
- Sector
- FATE Health Care
- FORR Consumer Discretionary
- Exchange
- FATE Nasdaq
- FORR Nasdaq
- Market Cap
- FATE 177.7M
- FORR 193.5M
- IPO Year
- FATE 2013
- FORR 1996
- Fundamental
- Price
- FATE $1.14
- FORR $9.92
- Analyst Decision
- FATE Hold
- FORR
- Analyst Count
- FATE 7
- FORR 0
- Target Price
- FATE $3.83
- FORR N/A
- AVG Volume (30 Days)
- FATE 1.9M
- FORR 65.0K
- Earning Date
- FATE 08-12-2025
- FORR 07-29-2025
- Dividend Yield
- FATE N/A
- FORR N/A
- EPS Growth
- FATE N/A
- FORR N/A
- EPS
- FATE N/A
- FORR N/A
- Revenue
- FATE $13,335,000.00
- FORR $422,269,000.00
- Revenue This Year
- FATE N/A
- FORR N/A
- Revenue Next Year
- FATE N/A
- FORR $2.04
- P/E Ratio
- FATE N/A
- FORR N/A
- Revenue Growth
- FATE 105.85
- FORR N/A
- 52 Week Low
- FATE $0.66
- FORR $8.50
- 52 Week High
- FATE $5.92
- FORR $20.62
- Technical
- Relative Strength Index (RSI)
- FATE 46.69
- FORR 45.44
- Support Level
- FATE $1.05
- FORR $10.10
- Resistance Level
- FATE $1.18
- FORR $11.00
- Average True Range (ATR)
- FATE 0.08
- FORR 0.42
- MACD
- FATE -0.00
- FORR 0.02
- Stochastic Oscillator
- FATE 54.76
- FORR 37.57
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.